Pathogenic Mechanisms in Thalassemia I: Ineffective Erythropoiesis and Hypercoagulability.

Bou-Fakhredin, Rayan; Rivella, Stefano; Cappellini, Maria Domenica; Taher, Ali T

Bou-Fakhredin, Rayan; Rivella, Stefano; Cappellini, Maria Domenica; Taher, Ali T.

Afiliación

Bou-Fakhredin R; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Rivella S; Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Cappellini MD; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; UOC General Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Taher AT; Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: ataher@aub.edu.lb.

Hematol Oncol Clin North Am ; 37(2): 341-351, 2023 04.

Article en En | MEDLINE | ID: mdl-36907607

Asunto(s)

Talasemia; Trombofilia; Talasemia beta; Humanos; Talasemia beta/terapia; Eritropoyesis; Talasemia/terapia; Eritrocitos

Palabras clave

Coagulopathy; Hypercoagulability; Ineffective erythropoiesis; Silent cerebral infarcts; Thrombosis; Vascular disease; ß-Thalassemia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Talasemia / Talasemia beta / Trombofilia Límite: Humans Idioma: En Revista: Hematol Oncol Clin North Am Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google